Search

everythinglearnresearchcommunity

for

Search:↓

Acne patients' skin, both with and without lesions, shows a strong immune response and higher antimicrobial activity.

Interferon gamma alone can't cause alopecia areata in C3H/HeJ mice.

Reducing CD8+ T cell growth can stabilize alopecia areata.

Cytotoxic T cells cause hair loss in chronic alopecia areata.

The conclusion is that a new method could improve the identification of autoimmune targets in alopecia areata, despite some limitations.

CD8+ T cells attack hair follicle stem cells, causing scarring and hair loss.

CD8+ virtual memory T cells may cause hair loss in alopecia areata.

Alopecia areata is an autoimmune disease that targets hair follicles.

Removing certain immune cells in mice causes their hair to enter the growth phase earlier than usual.

Allergic contact dermatitis may promote hair growth by activating hair follicle stem cells.

The condition is likely inherited in an autosomal-dominant pattern.

Diffuse alopecia areata causes widespread hair thinning due to an autoimmune response.

Regulatory T cells help prevent autoimmunity and have potential for treating autoimmune diseases.

Alopecia areata may be treated by using EGCG to balance immune cells and reduce inflammation.

Alopecia areata causes hair loss with varied treatment responses and frequent relapses.

Atopic dermatitis increases the risk of some autoimmune diseases.

Poor response to topical immunotherapy in alopecia areata patients is linked to impaired cell responses.

CD8+ T cells are involved in alopecia areata and may cause disease relapse.

Alopecia areata is likely an autoimmune disease with unclear triggers, involving various immune cells and molecules, and currently has no cure.

A compromised gut may trigger the autoimmune hair loss condition Alopecia Areata.

Treg cell-based therapies might help treat hair loss from alopecia areata, but more research is needed to confirm safety and effectiveness.

AIRE-deficient rats developed severe autoimmune disease similar to APECED, useful for testing treatments.

Alopecia areata involves immune activation in the scalp, suggesting treatments targeting TH1, TH2, and IL-23 pathways.

IBD patients treated with TNF antagonists may develop autoimmune alopecia areata, with severe cases less likely to improve.

Alopecia areata is an autoimmune disease affecting hair follicles and may harm heart health.

Alopecia areata involves immune system changes, especially in severe cases, with potential new treatment targets identified.

Alopecia areata is a chronic condition causing hair loss, with new treatments targeting the immune system showing promise.

Higher antigliadin antibody levels are linked to alopecia areata severity.

PD‐L1 and PD‐L2 may not effectively control immune activation in alopecia areata.